News FDA backs Novartis' Gilenya in paediatric MS First disease modifying therapy approved in paediatric MS
Partner Content Partner Content How RACE legislation is changing the face of pediatric oncol... On August 12 of this year the US senate unanimously passed the Race to Accelerate Cures and Equity for Children Act (RACE) expanding on the already enacted Pediatric Research Equity Act (P
News GW close to filing cannabis-based epilepsy drug Epidiolex could become a blockbuster if approved in all uses.
News EUSA Pharma approval fills gap in neuroblastoma market Company can move in after United Therapeutics withdrew its product Unituxin
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
